Medium-dose riboflavin as a prophylactic agent in children with migraine: A preliminary placebo-controlled, randomised, double-blind, cross-over trial

Quality of Life in Children with Primary Headache in a General Hospital

(2009) J Bruijn et al.   CEPHALALGIA

Riboflavin prophylaxis in pediatric and adolescent migraine

(2009) Maria Condò et al.   JOURNAL OF HEADACHE AND PAIN

Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs

(2009) C. Di Lorenzo et al.   NEUROLOGY

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for Migraine Prevention in Pediatric Subjects 12 to 17 Years of Age

(2009) D. Lewis et al.   PEDIATRICS

Placebo Efficacy in Childhood and Adolescence Migraine: An Analysis of Double-Blind and Placebo-Controlled Studies

(2008) S Evers et al.   CEPHALALGIA

High-Dose Ribof lavin for Migraine Prophylaxis in Children: A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Suzanna C. MacLennan et al.   JOURNAL OF CHILD NEUROLOGY